Gorlin Syndrome clinical trials at UCLA
1 research study open to eligible people
Showing trials for
Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults with Gorlin Syndrome
open to eligible people ages 18 years and up
The aim of this clinical study is to find out how well Patidegib Gel 2% works in preventing new basal cell carcinomas (BCCs) developing on the face of adults with Gorlin syndrome, and how safe Patidegib Gel 2% is to use. People who take part will…
Los Angeles, California and other locations
Last updated: